Due to worries about data privacy and misconduct, India's Union Health Ministry is taking strict measures against e-pharmacies, which are online platforms that sell medicines. The sale or distribution of any substance through the internet may be regulated, limited, or outright prohibited by the central government. The government is presently concentrating on how online pharmacies operate.

Indian Today Tech Apps like Tata 1mg and Netmeds may soon be prohibited from selling medications online due to potential norm violations. Due to worries about data privacy, malpractices, and the unjustified selling of drugs, the Union Health Ministry in India is exploring legislation and harsh measures against e-pharmacies. 

The central government is reportedly considering the option of regulating, limiting, or outright banning the sale or distribution of any drug via online channels in the revised draught of the New Drugs, Medical Devices, and Cosmetics Bill, 2023, which is currently undergoing inter-ministerial consultation. 

"The central government may regulate, restrict or prohibit the sale or distribution of any drug by online mode, by notification." the bill read. The Medicines and Cosmetics Act of 1940 is intended to be replaced by this measure. The provision in the previous draught bill that mandated authorization to run an online pharmacy has been removed in the new version.

Source- India Today